glp 1 for perimenopause weight loss GLP-1 Microdosing and Menopause: A Hormone-Aware Metabolic Framework Navigating weight changes during perimenopause

A: Not entirely

Lisdexamfetamine (Vyvanse) is the only medication specifically approved for moderate to severe BED in adults, typically used alongside psychotherapy

Ideal for patients seeking sustainable health benefits over time

Differences between GLP1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcomes, mean there may be benefits to switching from one to another

Its important to communicate regularly with your healthcare provider when you begin semaglutide treatment

GLP-1R agonists have shown potential benefits in muscle health by decreasing muscle atrophy and inflammation, as well as improving muscle microvasculature and endurance (68)